Simultaneous integrated boost for adjuvant treatment of breast cancer- intensity modulated vs. conventional radiotherapy: The IMRT-MC2 trial

被引：0
|
作者：
Vasileios Askoxylakis
Alexandra D Jensen
Matthias F Häfner
Leonie Fetzner
Florian Sterzing
Joerg Heil
Christof Sohn
Johannes Hüsing
Uta Tiefenbacher
Frederik Wenz
Jürgen Debus
Holger Hof
机构：
[1] University of Heidelberg,Department of Radiation Oncology
[2] University of Heidelberg,University Breast Center, Department of Gynecology
[3] University of Heidelberg,Coordination Centre for Clinical Trials
[4] Heidelberg University,Department of Radiation Oncology, University Medical Center Mannheim
来源：
BMC Cancer | / 11卷
关键词：
Intensity Modulate Radiation Therapy; Clinical Target Volume; Conventional Radiotherapy; Ipsilateral Breast Tumor Recurrence; Normal Tissue Complication Probability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Simultaneous integrated boost for adjuvant treatment of breast cancer- intensity modulated vs. conventional radiotherapy: The IMRT-MC2 trial
    Askoxylakis, Vasileios
    Jensen, Alexandra D.
    Haefner, Matthias F.
    Fetzner, Leonie
    Sterzing, Florian
    Heil, Joerg
    Sohn, Christof
    Huesing, Johannes
    Tiefenbacher, Uta
    Wenz, Frederik
    Debus, Juergen
    Hof, Holger
    [J]. BMC CANCER, 2011, 11
  • [2] Quality of Life After Simultaneously Integrated Boost With Intensity-Modulated vs. Conventional Radiotherapy Followed by Sequential Boost for Adjuvant Treatment of Breast Cancer: 2-Year Results of the Multicenter Randomized IMRT-MC2 Trial
    Forster, T.
    Hommertgen, A.
    Haefner, M. F.
    Arians, N.
    Laila, K.
    Harrabi, S.
    Schlampp, I.
    Koehler, C.
    Heinrich, V.
    Weidner, N.
    Huesing, J.
    Golatta, M.
    Sohn, C.
    Heil, J.
    Hof, H.
    Krug, D.
    Debus, J.
    Hoerner-Rieber, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S35 - S35
  • [3] Acute Toxicity of intensity modulated Radiotherapy with simultaneous integrated Boost in Patients with Breast Cancer - Data from the IMRT-MC2 (MINT) Study
    Krug, D.
    Koeder, C.
    Lossner, K.
    Haefner, M. F.
    Arians, N.
    Harrabi, S. B.
    Koerber, S. A.
    Schlampp, I
    Hoerner-Rieber, J.
    Heil, J.
    Hof, H.
    Debus, J.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S20 - S20
  • [4] Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial
    Forster, Tobias
    Hommertgen, Adriane
    Haefner, Matthias Felix
    Arians, Nathalie
    Koenig, Laila
    Ben Harrabi, Semi
    Schlampp, Ingmar
    Koehler, Clara
    Meixner, Eva
    Heinrich, Vanessa
    Weidner, Nicola
    Huesing, Johannes
    Sohn, Christof
    Heil, Joerg
    Golatta, Michael
    Hof, Holger
    Krug, David
    Debus, Juergen
    Hoerner-Rieber, Juliane
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 163 : 165 - 176
  • [5] Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result
    Lee, Hsin-Hua
    Hou, Ming-Feng
    Chuang, Hung-Yi
    Huang, Ming-Yii
    Tsuei, Le-Ping
    Chen, Fang-Ming
    Ou-Yang, Fu
    Huang, Chih-Jen
    [J]. BREAST, 2015, 24 (05): : 656 - 660
  • [6] Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial)
    Hoerner-Rieber, Juliane
    Forster, Tobias
    Hommertgen, Adriane
    Haefner, Matthias F.
    Arians, Nathalie
    Konig, Laila
    Harrabi, Semi B.
    Schlampp, Ingmar
    Weykamp, Fabian
    Lischalk, Jonathan W.
    Heinrich, Vanessa
    Weidner, Nicola
    Huesing, Johannes
    Sohn, Christof
    Heil, Joerrg
    Hof, Holger
    Krug, David
    Debus, Juergen
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (05): : 1311 - 1324
  • [7] 2-Year Quality of Life Data from the multicenter, randomized IMRT-MC2 Study: IMRT with simultaneously integrated Boost compared to conventional Radiation with sequential Boost in adjuvant Radiotherapy for Breast Cancer
    Forster, T.
    Hommertgen, A.
    Haefner, M.
    Arians, N.
    Koenig, L.
    Harrabi, S.
    Schlampp, I.
    Koehler, C.
    Meixner, E.
    Heinrich, V.
    Weidner, N.
    Huesing, J.
    Golatta, M.
    Sohn, C.
    Heil, J.
    Hof, H.
    Krug, D.
    Debus, J.
    Hoerner-Rieber, J.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S129 - S129
  • [8] Noninferiority of Local Control and Comparable Toxicity of Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Breast Cancer: 5-Year Results of the IMRT-MC2 Phase III Trial
    Forster, Tobias
    Koehler, Clara
    Dorn, Melissa
    Haefner, Matthias Felix
    Arians, Nathalie
    Koenig, Laila
    Ben Harrabi, Semi
    Schlampp, Ingmar
    Weykamp, Fabian
    Meixner, Eva
    Lang, Kristin
    Heinrich, Vanessa
    Weidner, Nicola
    Huesing, Johannes
    Wallwiener, Markus
    Golatta, Michael
    Hennigs, Andre
    Heil, Jorg
    Hof, Holger
    Krug, David
    Debus, Jurgen
    Hoerner-Rieber, Juliane
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (04): : 857 - 868
  • [9] Intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) in a patient with left breast cancer and pectus excavatum
    Ricardo Cendales
    Jaider Vasquez
    Juan Carlos Arbelaez
    Ivan Bobadilla
    Ricardo Espanol
    Felipe Torres
    Armando Gaitan
    [J]. Clinical and Translational Oncology, 2012, 14 : 747 - 754
  • [10] Intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) in a patient with left breast cancer and pectus excavatum
    Cendales, Ricardo
    Vasquez, Jaider
    Carlos Arbelaez, Juan
    Bobadilla, Ivan
    Espanol, Ricardo
    Torres, Felipe
    Gaitan, Armando
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (10): : 747 - 754
12345